A clinically attenuated double-mutant of porcine reproductive and respiratory syndrome virus-2 that does not prompt overexpression of proinflammatory cytokines during co-infection with a secondary pathogen
Porcine reproductive and respiratory syndrome virus (PRRSV) is known to suppress the type I interferon (IFNs-α/β) response during infection. PRRSV also activates the NF-κB signaling pathway, leading to the production of proinflammatory cytokines during infection. In swine farms, co-infections of PRR...
Saved in:
Published in | PLoS pathogens Vol. 20; no. 3; p. e1012128 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Public Library of Science
28.03.2024
Public Library of Science (PLoS) |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Porcine reproductive and respiratory syndrome virus (PRRSV) is known to suppress the type I interferon (IFNs-α/β) response during infection. PRRSV also activates the NF-κB signaling pathway, leading to the production of proinflammatory cytokines during infection. In swine farms, co-infections of PRRSV and other secondary bacterial pathogens are common and exacerbate the production of proinflammatory cytokines, contributing to the porcine respiratory disease complex (PRDC) which is clinically a severe disease. Previous studies identified the non-structural protein 1β (nsp1β) of PRRSV-2 as an IFN antagonist and the nucleocapsid (N) protein as the NF-κB activator. Further studies showed the leucine at position 126 (L126) of nsp1β as the essential residue for IFN suppression and the region spanning the nuclear localization signal (NLS) of N as the NF-κB activation domain. In the present study, we generated a double-mutant PRRSV-2 that contained the L126A mutation in the nsp1β gene and the NLS mutation (ΔNLS) in the N gene using reverse genetics. The immunological phenotype of this mutant PRRSV-2 was examined in porcine alveolar macrophages (PAMs) in vitro and in young pigs in vivo. In PAMs, the double-mutant virus did not suppress IFN-β expression but decreased the NF-κB-dependent inflammatory cytokine productions compared to those for wild-type PRRSV-2. Co-infection of PAMs with the mutant PRRSV-2 and
Streptococcus suis (S
.
suis)
also reduced the production of NF-κB-directed inflammatory cytokines. To further examine the cytokine profiles and the disease severity by the mutant virus in natural host animals, 6 groups of pigs, 7 animals per group, were used for co-infection with the mutant PRRSV-2 and
S
.
suis
. The double-mutant PRRSV-2 was clinically attenuated, and the expressions of proinflammatory cytokines and chemokines were significantly reduced in pigs after bacterial co-infection. Compared to the wild-type PRRSV-2 and
S
.
suis
co-infection control, pigs coinfected with the double-mutant PRRSV-2 exhibited milder clinical signs, lower titers and shorter duration of viremia, and lower expression of proinflammatory cytokines. In conclusion, our study demonstrates that genetic modification of the type I IFN suppression and NF-κB activation functions of PRRSV-2 may allow us to design a novel vaccine candidate to alleviate the clinical severity of PRRS-2 and PRDC during bacterial co-infection. |
---|---|
AbstractList | Porcine reproductive and respiratory syndrome virus (PRRSV) is known to suppress the type I interferon (IFNs-α/β) response during infection. PRRSV also activates the NF-κB signaling pathway, leading to the production of proinflammatory cytokines during infection. In swine farms, co-infections of PRRSV and other secondary bacterial pathogens are common and exacerbate the production of proinflammatory cytokines, contributing to the porcine respiratory disease complex (PRDC) which is clinically a severe disease. Previous studies identified the non-structural protein 1β (nsp1β) of PRRSV-2 as an IFN antagonist and the nucleocapsid (N) protein as the NF-κB activator. Further studies showed the leucine at position 126 (L126) of nsp1β as the essential residue for IFN suppression and the region spanning the nuclear localization signal (NLS) of N as the NF-κB activation domain. In the present study, we generated a double-mutant PRRSV-2 that contained the L126A mutation in the nsp1β gene and the NLS mutation (ΔNLS) in the N gene using reverse genetics. The immunological phenotype of this mutant PRRSV-2 was examined in porcine alveolar macrophages (PAMs) in vitro and in young pigs in vivo. In PAMs, the double-mutant virus did not suppress IFN-β expression but decreased the NF-κB-dependent inflammatory cytokine productions compared to those for wild-type PRRSV-2. Co-infection of PAMs with the mutant PRRSV-2 and Streptococcus suis (S. suis) also reduced the production of NF-κB-directed inflammatory cytokines. To further examine the cytokine profiles and the disease severity by the mutant virus in natural host animals, 6 groups of pigs, 7 animals per group, were used for co-infection with the mutant PRRSV-2 and S. suis. The double-mutant PRRSV-2 was clinically attenuated, and the expressions of proinflammatory cytokines and chemokines were significantly reduced in pigs after bacterial co-infection. Compared to the wild-type PRRSV-2 and S. suis co-infection control, pigs coinfected with the double-mutant PRRSV-2 exhibited milder clinical signs, lower titers and shorter duration of viremia, and lower expression of proinflammatory cytokines. In conclusion, our study demonstrates that genetic modification of the type I IFN suppression and NF-κB activation functions of PRRSV-2 may allow us to design a novel vaccine candidate to alleviate the clinical severity of PRRS-2 and PRDC during bacterial co-infection. Porcine reproductive and respiratory syndrome virus (PRRSV) is known to suppress the type I interferon (IFNs-α/β) response during infection. PRRSV also activates the NF-κB signaling pathway, leading to the production of proinflammatory cytokines during infection. In swine farms, co-infections of PRRSV and other secondary bacterial pathogens are common and exacerbate the production of proinflammatory cytokines, contributing to the porcine respiratory disease complex (PRDC) which is clinically a severe disease. Previous studies identified the non-structural protein 1β (nsp1β) of PRRSV-2 as an IFN antagonist and the nucleocapsid (N) protein as the NF-κB activator. Further studies showed the leucine at position 126 (L126) of nsp1β as the essential residue for IFN suppression and the region spanning the nuclear localization signal (NLS) of N as the NF-κB activation domain. In the present study, we generated a double-mutant PRRSV-2 that contained the L126A mutation in the nsp1β gene and the NLS mutation (ΔNLS) in the N gene using reverse genetics. The immunological phenotype of this mutant PRRSV-2 was examined in porcine alveolar macrophages (PAMs) in vitro and in young pigs in vivo. In PAMs, the double-mutant virus did not suppress IFN-β expression but decreased the NF-κB-dependent inflammatory cytokine productions compared to those for wild-type PRRSV-2. Co-infection of PAMs with the mutant PRRSV-2 and (. ) also reduced the production of NF-κB-directed inflammatory cytokines. To further examine the cytokine profiles and the disease severity by the mutant virus in natural host animals, 6 groups of pigs, 7 animals per group, were used for co-infection with the mutant PRRSV-2 and . . The double-mutant PRRSV-2 was clinically attenuated, and the expressions of proinflammatory cytokines and chemokines were significantly reduced in pigs after bacterial co-infection. Compared to the wild-type PRRSV-2 and . co-infection control, pigs coinfected with the double-mutant PRRSV-2 exhibited milder clinical signs, lower titers and shorter duration of viremia, and lower expression of proinflammatory cytokines. In conclusion, our study demonstrates that genetic modification of the type I IFN suppression and NF-κB activation functions of PRRSV-2 may allow us to design a novel vaccine candidate to alleviate the clinical severity of PRRS-2 and PRDC during bacterial co-infection. Porcine reproductive and respiratory syndrome virus (PRRSV) is known to suppress the type I interferon (IFNs-α/β) response during infection. PRRSV also activates the NF-κB signaling pathway, leading to the production of proinflammatory cytokines during infection. In swine farms, co-infections of PRRSV and other secondary bacterial pathogens are common and exacerbate the production of proinflammatory cytokines, contributing to the porcine respiratory disease complex (PRDC) which is clinically a severe disease. Previous studies identified the non-structural protein 1β (nsp1β) of PRRSV-2 as an IFN antagonist and the nucleocapsid (N) protein as the NF-κB activator. Further studies showed the leucine at position 126 (L126) of nsp1β as the essential residue for IFN suppression and the region spanning the nuclear localization signal (NLS) of N as the NF-κB activation domain. In the present study, we generated a double-mutant PRRSV-2 that contained the L126A mutation in the nsp1β gene and the NLS mutation (ΔNLS) in the N gene using reverse genetics. The immunological phenotype of this mutant PRRSV-2 was examined in porcine alveolar macrophages (PAMs) in vitro and in young pigs in vivo. In PAMs, the double-mutant virus did not suppress IFN-β expression but decreased the NF-κB-dependent inflammatory cytokine productions compared to those for wild-type PRRSV-2. Co-infection of PAMs with the mutant PRRSV-2 and Streptococcus suis (S . suis) also reduced the production of NF-κB-directed inflammatory cytokines. To further examine the cytokine profiles and the disease severity by the mutant virus in natural host animals, 6 groups of pigs, 7 animals per group, were used for co-infection with the mutant PRRSV-2 and S . suis . The double-mutant PRRSV-2 was clinically attenuated, and the expressions of proinflammatory cytokines and chemokines were significantly reduced in pigs after bacterial co-infection. Compared to the wild-type PRRSV-2 and S . suis co-infection control, pigs coinfected with the double-mutant PRRSV-2 exhibited milder clinical signs, lower titers and shorter duration of viremia, and lower expression of proinflammatory cytokines. In conclusion, our study demonstrates that genetic modification of the type I IFN suppression and NF-κB activation functions of PRRSV-2 may allow us to design a novel vaccine candidate to alleviate the clinical severity of PRRS-2 and PRDC during bacterial co-infection. Porcine reproductive and respiratory syndrome virus (PRRSV) is a significant swine pathogen worldwide. PRRSV suppresses the type I interferon (IFN) response and activates the NF-κB signaling, leading to the production of proinflammatory cytokines. Co-infection of PRRSV and a secondary pathogen is common in farms and exacerbates the production of proinflammatory cytokines, contributing to the porcine respiratory disease complex (PRDC) which is a clinically severe disease. Here, we generated a double-mutant PRRSV-2 in the nsp1β and N genes by reverse genetics. In cells, the mutant virus did not suppress IFN expression and reduced the NF-κB-mediated inflammatory cytokines compared to wild-type PRRSV-2. Co-infection of macrophages with the mutant virus and Streptococcus suis reduced the production of inflammatory cytokines. The immunological phenotypes of the mutant PRRSV-2 were examined in pigs, 6 groups of pigs, 7 animals per group, after co-infection with S . suis . The double-mutant PRRSV-2 was clinically attenuated, and the expressions of proinflammatory cytokines were significantly reduced in pigs after bacterial co-infection. Our study provides insights that the reprogramming of viral immune antagonism may allow to design of a novel vaccine candidate to alleviate the clinical severity of PRRS and PRDC during co-infection. Porcine reproductive and respiratory syndrome virus (PRRSV) is known to suppress the type I interferon (IFNs-α/β) response during infection. PRRSV also activates the NF-κB signaling pathway, leading to the production of proinflammatory cytokines during infection. In swine farms, co-infections of PRRSV and other secondary bacterial pathogens are common and exacerbate the production of proinflammatory cytokines, contributing to the porcine respiratory disease complex (PRDC) which is clinically a severe disease. Previous studies identified the non-structural protein 1β (nsp1β) of PRRSV-2 as an IFN antagonist and the nucleocapsid (N) protein as the NF-κB activator. Further studies showed the leucine at position 126 (L126) of nsp1β as the essential residue for IFN suppression and the region spanning the nuclear localization signal (NLS) of N as the NF-κB activation domain. In the present study, we generated a double-mutant PRRSV-2 that contained the L126A mutation in the nsp1β gene and the NLS mutation (ΔNLS) in the N gene using reverse genetics. The immunological phenotype of this mutant PRRSV-2 was examined in porcine alveolar macrophages (PAMs) in vitro and in young pigs in vivo. In PAMs, the double-mutant virus did not suppress IFN-β expression but decreased the NF-κB-dependent inflammatory cytokine productions compared to those for wild-type PRRSV-2. Co-infection of PAMs with the mutant PRRSV-2 and Streptococcus suis (S. suis) also reduced the production of NF-κB-directed inflammatory cytokines. To further examine the cytokine profiles and the disease severity by the mutant virus in natural host animals, 6 groups of pigs, 7 animals per group, were used for co-infection with the mutant PRRSV-2 and S. suis. The double-mutant PRRSV-2 was clinically attenuated, and the expressions of proinflammatory cytokines and chemokines were significantly reduced in pigs after bacterial co-infection. Compared to the wild-type PRRSV-2 and S. suis co-infection control, pigs coinfected with the double-mutant PRRSV-2 exhibited milder clinical signs, lower titers and shorter duration of viremia, and lower expression of proinflammatory cytokines. In conclusion, our study demonstrates that genetic modification of the type I IFN suppression and NF-κB activation functions of PRRSV-2 may allow us to design a novel vaccine candidate to alleviate the clinical severity of PRRS-2 and PRDC during bacterial co-infection.Porcine reproductive and respiratory syndrome virus (PRRSV) is known to suppress the type I interferon (IFNs-α/β) response during infection. PRRSV also activates the NF-κB signaling pathway, leading to the production of proinflammatory cytokines during infection. In swine farms, co-infections of PRRSV and other secondary bacterial pathogens are common and exacerbate the production of proinflammatory cytokines, contributing to the porcine respiratory disease complex (PRDC) which is clinically a severe disease. Previous studies identified the non-structural protein 1β (nsp1β) of PRRSV-2 as an IFN antagonist and the nucleocapsid (N) protein as the NF-κB activator. Further studies showed the leucine at position 126 (L126) of nsp1β as the essential residue for IFN suppression and the region spanning the nuclear localization signal (NLS) of N as the NF-κB activation domain. In the present study, we generated a double-mutant PRRSV-2 that contained the L126A mutation in the nsp1β gene and the NLS mutation (ΔNLS) in the N gene using reverse genetics. The immunological phenotype of this mutant PRRSV-2 was examined in porcine alveolar macrophages (PAMs) in vitro and in young pigs in vivo. In PAMs, the double-mutant virus did not suppress IFN-β expression but decreased the NF-κB-dependent inflammatory cytokine productions compared to those for wild-type PRRSV-2. Co-infection of PAMs with the mutant PRRSV-2 and Streptococcus suis (S. suis) also reduced the production of NF-κB-directed inflammatory cytokines. To further examine the cytokine profiles and the disease severity by the mutant virus in natural host animals, 6 groups of pigs, 7 animals per group, were used for co-infection with the mutant PRRSV-2 and S. suis. The double-mutant PRRSV-2 was clinically attenuated, and the expressions of proinflammatory cytokines and chemokines were significantly reduced in pigs after bacterial co-infection. Compared to the wild-type PRRSV-2 and S. suis co-infection control, pigs coinfected with the double-mutant PRRSV-2 exhibited milder clinical signs, lower titers and shorter duration of viremia, and lower expression of proinflammatory cytokines. In conclusion, our study demonstrates that genetic modification of the type I IFN suppression and NF-κB activation functions of PRRSV-2 may allow us to design a novel vaccine candidate to alleviate the clinical severity of PRRS-2 and PRDC during bacterial co-infection. Porcine reproductive and respiratory syndrome virus (PRRSV) is known to suppress the type I interferon (IFNs-[alpha]/[beta]) response during infection. PRRSV also activates the NF-[kappa]B signaling pathway, leading to the production of proinflammatory cytokines during infection. In swine farms, co-infections of PRRSV and other secondary bacterial pathogens are common and exacerbate the production of proinflammatory cytokines, contributing to the porcine respiratory disease complex (PRDC) which is clinically a severe disease. Previous studies identified the non-structural protein 1[beta] (nsp1[beta]) of PRRSV-2 as an IFN antagonist and the nucleocapsid (N) protein as the NF-[kappa]B activator. Further studies showed the leucine at position 126 (L126) of nsp1[beta] as the essential residue for IFN suppression and the region spanning the nuclear localization signal (NLS) of N as the NF-[kappa]B activation domain. In the present study, we generated a double-mutant PRRSV-2 that contained the L126A mutation in the nsp1[beta] gene and the NLS mutation ([DELTA]NLS) in the N gene using reverse genetics. The immunological phenotype of this mutant PRRSV-2 was examined in porcine alveolar macrophages (PAMs) in vitro and in young pigs in vivo. In PAMs, the double-mutant virus did not suppress IFN-[beta] expression but decreased the NF-[kappa]B-dependent inflammatory cytokine productions compared to those for wild-type PRRSV-2. Co-infection of PAMs with the mutant PRRSV-2 and Streptococcus suis (S. suis) also reduced the production of NF-[kappa]B-directed inflammatory cytokines. To further examine the cytokine profiles and the disease severity by the mutant virus in natural host animals, 6 groups of pigs, 7 animals per group, were used for co-infection with the mutant PRRSV-2 and S. suis. The double-mutant PRRSV-2 was clinically attenuated, and the expressions of proinflammatory cytokines and chemokines were significantly reduced in pigs after bacterial co-infection. Compared to the wild-type PRRSV-2 and S. suis co-infection control, pigs coinfected with the double-mutant PRRSV-2 exhibited milder clinical signs, lower titers and shorter duration of viremia, and lower expression of proinflammatory cytokines. In conclusion, our study demonstrates that genetic modification of the type I IFN suppression and NF-[kappa]B activation functions of PRRSV-2 may allow us to design a novel vaccine candidate to alleviate the clinical severity of PRRS-2 and PRDC during bacterial co-infection. Porcine reproductive and respiratory syndrome virus (PRRSV) is known to suppress the type I interferon (IFNs-α/β) response during infection. PRRSV also activates the NF-κB signaling pathway, leading to the production of proinflammatory cytokines during infection. In swine farms, co-infections of PRRSV and other secondary bacterial pathogens are common and exacerbate the production of proinflammatory cytokines, contributing to the porcine respiratory disease complex (PRDC) which is clinically a severe disease. Previous studies identified the non-structural protein 1β (nsp1β) of PRRSV-2 as an IFN antagonist and the nucleocapsid (N) protein as the NF-κB activator. Further studies showed the leucine at position 126 (L126) of nsp1β as the essential residue for IFN suppression and the region spanning the nuclear localization signal (NLS) of N as the NF-κB activation domain. In the present study, we generated a double-mutant PRRSV-2 that contained the L126A mutation in the nsp1β gene and the NLS mutation (ΔNLS) in the N gene using reverse genetics. The immunological phenotype of this mutant PRRSV-2 was examined in porcine alveolar macrophages (PAMs) in vitro and in young pigs in vivo. In PAMs, the double-mutant virus did not suppress IFN-β expression but decreased the NF-κB-dependent inflammatory cytokine productions compared to those for wild-type PRRSV-2. Co-infection of PAMs with the mutant PRRSV-2 and Streptococcus suis (S . suis) also reduced the production of NF-κB-directed inflammatory cytokines. To further examine the cytokine profiles and the disease severity by the mutant virus in natural host animals, 6 groups of pigs, 7 animals per group, were used for co-infection with the mutant PRRSV-2 and S . suis . The double-mutant PRRSV-2 was clinically attenuated, and the expressions of proinflammatory cytokines and chemokines were significantly reduced in pigs after bacterial co-infection. Compared to the wild-type PRRSV-2 and S . suis co-infection control, pigs coinfected with the double-mutant PRRSV-2 exhibited milder clinical signs, lower titers and shorter duration of viremia, and lower expression of proinflammatory cytokines. In conclusion, our study demonstrates that genetic modification of the type I IFN suppression and NF-κB activation functions of PRRSV-2 may allow us to design a novel vaccine candidate to alleviate the clinical severity of PRRS-2 and PRDC during bacterial co-infection. |
Audience | Academic |
Author | Su, Chia-Ming Kim, Jineui Tang, Junyu Husmann, Robert Kim, Jiyoun Lee, Young-Min Hung, Yu Fan Roady, Patrick Yoo, Dongwan Zuckermann, Federico A. |
AuthorAffiliation | 3 Department of Animal, Dairy, and Veterinary Sciences, Utah State University, Logan, Utah, United States of America 2 Department of Veterinary Clinical Medicine, College of Veterinary Medicine, University of Illinois at Urbana-Champaign, Urbana, Illinois, United States of America Leiden University Medical Center, NETHERLANDS 1 Department of Pathobiology, College of Veterinary Medicine, University of Illinois at Urbana-Champaign, Urbana, Illinois, United States of America |
AuthorAffiliation_xml | – name: 1 Department of Pathobiology, College of Veterinary Medicine, University of Illinois at Urbana-Champaign, Urbana, Illinois, United States of America – name: 3 Department of Animal, Dairy, and Veterinary Sciences, Utah State University, Logan, Utah, United States of America – name: Leiden University Medical Center, NETHERLANDS – name: 2 Department of Veterinary Clinical Medicine, College of Veterinary Medicine, University of Illinois at Urbana-Champaign, Urbana, Illinois, United States of America |
Author_xml | – sequence: 1 givenname: Chia-Ming surname: Su fullname: Su, Chia-Ming – sequence: 2 givenname: Jineui surname: Kim fullname: Kim, Jineui – sequence: 3 givenname: Junyu surname: Tang fullname: Tang, Junyu – sequence: 4 givenname: Yu Fan surname: Hung fullname: Hung, Yu Fan – sequence: 5 givenname: Federico A. surname: Zuckermann fullname: Zuckermann, Federico A. – sequence: 6 givenname: Robert surname: Husmann fullname: Husmann, Robert – sequence: 7 givenname: Patrick surname: Roady fullname: Roady, Patrick – sequence: 8 givenname: Jiyoun surname: Kim fullname: Kim, Jiyoun – sequence: 9 givenname: Young-Min surname: Lee fullname: Lee, Young-Min – sequence: 10 givenname: Dongwan orcidid: 0000-0002-6730-9729 surname: Yoo fullname: Yoo, Dongwan |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/38547254$$D View this record in MEDLINE/PubMed |
BookMark | eNqVk9tu1DAQhiNURA_wBggscQMXWew4R27QquJQqQKJw7Xl2JNdl8QOtrN0H5J3Yra7rbpVhUC5SDT-_n_GM5nj5MA6C0nylNEZ4xV7feEmb2U_G0cZZ4yyjGX1g-SIFQVPK17lB7e-D5PjEC4ozRln5aPkkNdFXmVFfpT8nhPVG2uU7Ps1kTGCnWQETbSb2h7SYYrSRuI6MjqvjAXiYfROTyqaFRBpNQbCaLyMzq9JWFvt3QBkZfwU0ozEpYzoBYFYFwkqhxHdVuDhckRhMM5emXtnbNfLYdj6qHV0PzBbIHryxi6IcikCgFlR8MvEJZEkgHJWS8SxBUu3APs4edjJPsCT3fsk-f7-3bfTj-n55w9np_PzVJVNEVNG2wq6GtqKNl0uM1azoqUadMPbkiuqeFHmDeNadi1iXFa8LlUNTaZbyUHzk-T51nfsXRC7SQTBadmwmvOiQuJsS2gnL8TozYB1CieNuAo4vxDSR6N6EDmjWV7ljc5onXcNbVReSgqFVFwVUDD0ervLNrUDaAU2etnvme6fWLMUC7cSjFHKyyZHh5c7B-9-ThCiGExQ0PfSgpuwcFYg1xTVP6A0y4oq4yVF9MUd9P5O7KiFxMviEB3WqDamYl7VNS_rjJZIze6h8NEwGBwzdAbje4JXewJkIlzGhZxCEGdfv_wH-2mffXa72Tddvl4ZBPItoLwLwUN3gzAqNpt53QWx2Uyx20yUvbkjUybKze-MFzX938V_ADyxRag |
CitedBy_id | crossref_primary_10_1186_s13567_024_01390_y crossref_primary_10_1016_j_vetmic_2024_110243 crossref_primary_10_1016_j_virol_2025_110484 crossref_primary_10_1016_j_virol_2024_110378 |
Cites_doi | 10.1002/eji.200635993 10.1128/JVI.00177-12 10.1186/1743-422X-7-184 10.1182/blood-2008-11-188458 10.1038/s41598-019-47495-9 10.1016/j.virol.2017.02.004 10.1016/j.vetmic.2017.03.014 10.1371/journal.pone.0016577 10.1099/jgv.0.001632 10.4049/jimmunol.176.6.3315 10.1128/JVI.79.12.7535-7543.2005 10.1128/CMR.00111-17 10.1007/978-1-4615-5331-1_59 10.1371/journal.pone.0040865 10.1016/j.vetmic.2015.08.026 10.1128/JVI.05941-11 10.1016/j.vetimm.2015.07.003 10.1006/meth.2001.1262 10.1053/rvsc.1998.0277 10.4049/jimmunol.174.8.4465 10.1128/iai.00574-21 10.1084/jem.20050821 10.1038/s41598-018-31554-8 10.1128/JVI.01646-08 10.1002/jcla.24881 10.4049/jimmunol.176.8.4682 10.1007/s00281-017-0639-8 10.3390/v4040424 10.3389/fmicb.2023.1159590 10.1354/vp.37-2-143 10.4049/jimmunol.176.8.4525 10.1007/978-0-387-33012-9_25 10.1371/journal.pone.0156019 10.1038/ni978 10.1038/icb.2012.10 10.1016/j.tvjl.2015.10.030 10.1016/j.virusres.2014.11.006 10.1038/cmi.2015.74 10.1016/j.virol.2009.11.033 10.1128/JVI.00655-10 10.1038/s41590-022-01160-y 10.1146/annurev.immunol.16.1.27 10.1016/j.virol.2005.07.034 10.1146/annurev-immunol-032713-120231 10.1089/vim.2010.0051 10.1016/j.virol.2010.08.025 10.4049/jimmunol.178.9.5839 10.1016/S0749-0720(15)30006-2 10.1006/viro.2002.1612 10.1016/j.virusres.2014.09.007 10.1111/tbed.13072 10.1128/JVI.02360-14 10.1371/journal.ppat.1002407 10.1016/j.vetmic.2017.03.035 10.4049/jimmunol.0900592 10.1128/JVI.73.1.270-280.1999 10.1128/CVI.00304-06 10.1093/emboj/cdg267 10.1016/j.virol.2016.03.005 10.1016/S0165-2427(97)00134-7 10.1016/j.virol.2018.01.016 10.1016/j.vetimm.2010.01.002 10.4049/jimmunol.177.3.1746 10.1177/030098589503200606 10.4049/jimmunol.176.4.2074 10.1186/1743-422X-9-83 10.1128/JVI.01396-14 10.1016/j.virol.2010.03.039 10.1099/vir.0.014001-0 10.3201/eid1902.120470 10.1016/j.virol.2005.11.005 10.1016/j.molimm.2010.10.022 10.1016/j.virusres.2008.02.012 10.4049/jimmunol.1001140 10.1007/s007050070022 10.1093/oxfordjournals.aje.a118408 10.1007/s12016-021-08908-8 10.1016/S0968-0004(99)01530-3 |
ContentType | Journal Article |
Copyright | Copyright: © 2024 Su et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. COPYRIGHT 2024 Public Library of Science 2024 Su et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2024 Su et al 2024 Su et al 2024 Su et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
Copyright_xml | – notice: Copyright: © 2024 Su et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. – notice: COPYRIGHT 2024 Public Library of Science – notice: 2024 Su et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2024 Su et al 2024 Su et al – notice: 2024 Su et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
DBID | AAYXX CITATION NPM ISN ISR 3V. 7QL 7U9 7X7 7XB 88E 8FE 8FH 8FI 8FJ 8FK ABUWG AEUYN AFKRA AZQEC BBNVY BENPR BHPHI C1K CCPQU DWQXO FYUFA GHDGH GNUQQ H94 HCIFZ K9. LK8 M0S M1P M7P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI 7X8 7S9 L.6 5PM DOA |
DOI | 10.1371/journal.ppat.1012128 |
DatabaseName | CrossRef PubMed Gale In Context: Canada Gale In Context: Science ProQuest Central (Corporate) Bacteriology Abstracts (Microbiology B) Virology and AIDS Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni Edition) ProQuest One Sustainability ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) ProQuest Biological Science Collection Health & Medical Collection (Alumni Edition) Medical Database Biological Science Database ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition MEDLINE - Academic AGRICOLA AGRICOLA - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef PubMed Publicly Available Content Database ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection Environmental Sciences and Pollution Management ProQuest Central ProQuest One Applied & Life Sciences ProQuest One Sustainability ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Health & Medical Research Collection Biological Science Collection AIDS and Cancer Research Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) Virology and AIDS Abstracts ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic AGRICOLA AGRICOLA - Academic |
DatabaseTitleList | AGRICOLA MEDLINE - Academic Publicly Available Content Database PubMed CrossRef |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
DocumentTitleAlternate | Type I interferon suppression-negative and NF-κB activation-negative PRRSV |
EISSN | 1553-7374 |
ExternalDocumentID | 3069183357 oai_doaj_org_article_41024749d2084f909c46a0e5ac3c5e51 PMC11003694 A788368206 38547254 10_1371_journal_ppat_1012128 |
Genre | Journal Article |
GeographicLocations | United States |
GeographicLocations_xml | – name: United States |
GrantInformation_xml | – fundername: ; grantid: 2018-67016-28296 – fundername: ; grantid: ILLU-888-944 – fundername: ; grantid: 2018-67015-28287 – fundername: ; grantid: 2023-67015-39710 |
GroupedDBID | --- 123 29O 2WC 53G 5VS 7X7 88E 8FE 8FH 8FI 8FJ AAFWJ AAUCC AAWOE AAYXX ABDBF ABUWG ACGFO ACIHN ACPRK ACUHS ADBBV AEAQA AENEX AEUYN AFKRA AFPKN AFRAH AHMBA ALMA_UNASSIGNED_HOLDINGS AOIJS B0M BAWUL BBNVY BCNDV BENPR BHPHI BPHCQ BVXVI BWKFM CCPQU CITATION CS3 DIK DU5 E3Z EAP EAS EBD EMK EMOBN ESX F5P FPL FYUFA GROUPED_DOAJ GX1 HCIFZ HMCUK HYE IAO IHR INH INR ISN ISR ITC KQ8 LK8 M1P M48 M7P MM. O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO PV9 QF4 QN7 RNS RPM RZL SV3 TR2 TUS UKHRP WOW ~8M NPM PJZUB PPXIY PQGLB PMFND 3V. 7QL 7U9 7XB 8FK AZQEC C1K DWQXO GNUQQ H94 K9. PKEHL PQEST PQUKI 7X8 7S9 L.6 5PM PUEGO |
ID | FETCH-LOGICAL-c695t-10b7ef8eb709f4a21815b0ded93b63c0c3564913dafbf8e3a7386c8e92dba3ed3 |
IEDL.DBID | M48 |
ISSN | 1553-7374 1553-7366 |
IngestDate | Tue Aug 12 00:50:56 EDT 2025 Wed Aug 27 01:23:27 EDT 2025 Thu Aug 21 18:34:05 EDT 2025 Thu Jul 10 19:22:53 EDT 2025 Thu Jul 10 20:00:03 EDT 2025 Fri Jul 25 12:09:59 EDT 2025 Tue Jun 17 22:14:05 EDT 2025 Tue Jun 10 21:11:13 EDT 2025 Fri Jun 27 06:01:02 EDT 2025 Fri Jun 27 05:49:28 EDT 2025 Mon Jul 21 05:53:39 EDT 2025 Thu Apr 24 22:50:23 EDT 2025 Tue Jul 01 01:05:40 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Language | English |
License | Copyright: © 2024 Su et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Creative Commons Attribution License |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c695t-10b7ef8eb709f4a21815b0ded93b63c0c3564913dafbf8e3a7386c8e92dba3ed3 |
Notes | new_version ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 Current address: Department of Biochemistry and Cell Biology, School of Medicine, Boston University, Boston, Massachusetts, United States of America Current address: Department of Microbiology, Institute for Viral Diseases, Vaccine Innovation Center, College of Medicine, Korea University, Seoul, Korea The authors have declared that no competing interests exist. |
ORCID | 0000-0002-6730-9729 |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1371/journal.ppat.1012128 |
PMID | 38547254 |
PQID | 3069183357 |
PQPubID | 1436335 |
PageCount | e1012128 |
ParticipantIDs | plos_journals_3069183357 doaj_primary_oai_doaj_org_article_41024749d2084f909c46a0e5ac3c5e51 pubmedcentral_primary_oai_pubmedcentral_nih_gov_11003694 proquest_miscellaneous_3153699574 proquest_miscellaneous_3022572360 proquest_journals_3069183357 gale_infotracmisc_A788368206 gale_infotracacademiconefile_A788368206 gale_incontextgauss_ISR_A788368206 gale_incontextgauss_ISN_A788368206 pubmed_primary_38547254 crossref_primary_10_1371_journal_ppat_1012128 crossref_citationtrail_10_1371_journal_ppat_1012128 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 20240328 |
PublicationDateYYYYMMDD | 2024-03-28 |
PublicationDate_xml | – month: 3 year: 2024 text: 20240328 day: 28 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: San Francisco – name: San Francisco, CA USA |
PublicationTitle | PLoS pathogens |
PublicationTitleAlternate | PLoS Pathog |
PublicationYear | 2024 |
Publisher | Public Library of Science Public Library of Science (PLoS) |
Publisher_xml | – name: Public Library of Science – name: Public Library of Science (PLoS) |
References | GA Kolumam (ppat.1012128.ref008) 2005; 202 P Bach (ppat.1012128.ref017) 2007; 178 E Albina (ppat.1012128.ref021) 1998; 61 LJ Thompson (ppat.1012128.ref016) 2006; 177 C Song (ppat.1012128.ref031) 2010; 407 WE Purtha (ppat.1012128.ref019) 2008; 82 FA Zuckermann (ppat.1012128.ref080) 2022; 90 S Wootton (ppat.1012128.ref026) 2000; 145 JC Miguel (ppat.1012128.ref072) 2010; 135 KS Makarova (ppat.1012128.ref046) 2000; 25 Y Fang (ppat.1012128.ref036) 2012; 9 K Jung (ppat.1012128.ref058) 2009; 90 J Li (ppat.1012128.ref044) 2017; 204 NT Hoa (ppat.1012128.ref050) 2013; 19 CL Loving (ppat.1012128.ref068) 2015; 167 DJ Thomas (ppat.1012128.ref082) 2011; 6 H Ke (ppat.1012128.ref062) 2018; 517 SM Lee (ppat.1012128.ref074) 2005; 342 LJ REED (ppat.1012128.ref083) 1938; 27 OJ Lopez (ppat.1012128.ref066) 2007; 14 GJ Renukaradhya (ppat.1012128.ref059) 2010; 23 Y Wang (ppat.1012128.ref053) 2011; 48 A Le Bon (ppat.1012128.ref010) 2003; 4 J Li (ppat.1012128.ref060) 2019; 66 HJ Ramos (ppat.1012128.ref015) 2009; 113 C Havenar-Daughton (ppat.1012128.ref002) 2006; 176 H Ke (ppat.1012128.ref027) 2017; 209 CJ Nelsen (ppat.1012128.ref025) 1999; 73 SJ Keppler (ppat.1012128.ref007) 2012; 7 A Le Bon (ppat.1012128.ref009) 2006; 176 N Kumar (ppat.1012128.ref069) 2018; 31 HD Marshall (ppat.1012128.ref006) 2010; 185 WP Arend (ppat.1012128.ref056) 1998; 16 S Tahtinen (ppat.1012128.ref057) 2022; 23 KJ Livak (ppat.1012128.ref079) 2001; 25 O Kim (ppat.1012128.ref047) 2010; 402 WM Schneider (ppat.1012128.ref001) 2014; 32 M Han (ppat.1012128.ref029) 2014; 194 M Han (ppat.1012128.ref033) 2017; 505 G Auray (ppat.1012128.ref043) 2016; 11 M Xu (ppat.1012128.ref061) 2010; 7 S Qin (ppat.1012128.ref039) 2018; 8 SL Brockmeier (ppat.1012128.ref049) 2002 WY Chen (ppat.1012128.ref071) 2018; 92 D Patel (ppat.1012128.ref030) 2010; 84 W Buddaert (ppat.1012128.ref022) 1998; 440 Y Fu (ppat.1012128.ref073) 2012; 86 S Wang (ppat.1012128.ref051) 2023; 14 FA Osorio (ppat.1012128.ref067) 2002; 302 RN Jennings (ppat.1012128.ref014) 2014; 88 L Kavanová (ppat.1012128.ref077) 2015; 180 HM Elbadawy (ppat.1012128.ref055) 2023; 37 C. Chae (ppat.1012128.ref040) 2016; 212 BG Chousterman (ppat.1012128.ref041) 2017; 39 H Ke (ppat.1012128.ref032) 2019; 93 Y Sun (ppat.1012128.ref035) 2012; 4 A Le Bon (ppat.1012128.ref003) 2006; 176 K Fink (ppat.1012128.ref018) 2006; 36 JM Curtsinger (ppat.1012128.ref005) 2005; 174 N Sun (ppat.1012128.ref045) 2016; 6 K Kiefer (ppat.1012128.ref020) 2012; 90 C Huang (ppat.1012128.ref034) 2014; 88 EL Thacker (ppat.1012128.ref048) 2001; 17 B Li (ppat.1012128.ref078) 2015; 196 K Van Reeth (ppat.1012128.ref023) 1999; 67 C Lee (ppat.1012128.ref052) 2006; 346 FD Segundo (ppat.1012128.ref064) 2012; 86 MA Brinton (ppat.1012128.ref024) 2021; 102 C Lee (ppat.1012128.ref075) 2006; 581 R Thanawongnuwech (ppat.1012128.ref038) 2000; 37 R Qin (ppat.1012128.ref054) 2023; 64 A Solórzano (ppat.1012128.ref065) 2005; 79 MG Santoro (ppat.1012128.ref070) 2003; 22 Y Pei (ppat.1012128.ref076) 2008; 135 SL Urban (ppat.1012128.ref011) 2016; 493 P Agarwal (ppat.1012128.ref013) 2009; 183 Y Li (ppat.1012128.ref063) 2014; 111 P Aichele (ppat.1012128.ref004) 2006; 176 Z Chen (ppat.1012128.ref028) 2010; 398 Q Liu (ppat.1012128.ref042) 2016; 13 AK Pinto (ppat.1012128.ref012) 2011; 7 H Ke (ppat.1012128.ref037) 2019; 9 PG Halbur (ppat.1012128.ref081) 1995; 32 |
References_xml | – volume: 36 start-page: 2094 issue: 8 year: 2006 ident: ppat.1012128.ref018 article-title: Early type I interferon-mediated signals on B cells specifically enhance antiviral humoral responses publication-title: Eur J Immunol doi: 10.1002/eji.200635993 – volume: 86 start-page: 7625 issue: 14 year: 2012 ident: ppat.1012128.ref073 article-title: Porcine reproductive and respiratory syndrome virus induces interleukin-15 through the NF-κB signaling pathway publication-title: J Virol doi: 10.1128/JVI.00177-12 – volume: 7 start-page: 184 year: 2010 ident: ppat.1012128.ref061 article-title: Secondary infection with Streptococcus suis serotype 7 increases the virulence of highly pathogenic porcine reproductive and respiratory syndrome virus in pigs. publication-title: Virol J. doi: 10.1186/1743-422X-7-184 – volume: 113 start-page: 5516 issue: 22 year: 2009 ident: ppat.1012128.ref015 article-title: Reciprocal responsiveness to interleukin-12 and interferon-alpha specifies human CD8+ effector versus central memory T-cell fates publication-title: Blood doi: 10.1182/blood-2008-11-188458 – volume: 9 start-page: 11042 issue: 1 year: 2019 ident: ppat.1012128.ref037 article-title: Interaction of PIAS1 with PRRS virus nucleocapsid protein mediates NF-κB activation and triggers proinflammatory mediators during viral infection. publication-title: Sci Rep. doi: 10.1038/s41598-019-47495-9 – volume: 505 start-page: 42 year: 2017 ident: ppat.1012128.ref033 article-title: Nuclear imprisonment of host cellular mRNA by nsp1β protein of porcine reproductive and respiratory syndrome virus publication-title: Virology doi: 10.1016/j.virol.2017.02.004 – volume: 209 start-page: 75 year: 2017 ident: ppat.1012128.ref027 article-title: The viral innate immune antagonism and an alternative vaccine design for PRRS virus publication-title: Vet Microbiol doi: 10.1016/j.vetmic.2017.03.014 – volume: 6 start-page: e16577 issue: 2 year: 2011 ident: ppat.1012128.ref082 article-title: Lactobacillus rhamnosus HN001 attenuates allergy development in a pig model publication-title: PLoS One doi: 10.1371/journal.pone.0016577 – volume: 102 issue: 8 year: 2021 ident: ppat.1012128.ref024 article-title: ICTV Virus Taxonomy Profile: Arteriviridae 2021 publication-title: J Gen Virol doi: 10.1099/jgv.0.001632 – volume: 176 start-page: 3315 issue: 6 year: 2006 ident: ppat.1012128.ref002 article-title: Cutting Edge: The direct action of type I IFN on CD4 T cells is critical for sustaining clonal expansion in response to a viral but not a bacterial infection publication-title: J Immunol doi: 10.4049/jimmunol.176.6.3315 – volume: 79 start-page: 7535 issue: 12 year: 2005 ident: ppat.1012128.ref065 article-title: Mutations in the NS1 protein of swine influenza virus impair anti-interferon activity and confer attenuation in pigs publication-title: J Virol doi: 10.1128/JVI.79.12.7535-7543.2005 – volume: 31 issue: 4 year: 2018 ident: ppat.1012128.ref069 article-title: Virological and Immunological Outcomes of Coinfections. publication-title: Clin Microbiol Rev doi: 10.1128/CMR.00111-17 – volume: 440 start-page: 461 year: 1998 ident: ppat.1012128.ref022 article-title: In vivo and in vitro interferon (IFN) studies with the porcine reproductive and respiratory syndrome virus (PRRSV). publication-title: Adv Exp Med Biol doi: 10.1007/978-1-4615-5331-1_59 – volume: 7 start-page: e40865 issue: 7 year: 2012 ident: ppat.1012128.ref007 article-title: Signal 3 cytokines as modulators of primary immune responses during infections: the interplay of type I IFN and IL-12 in CD8 T cell responses publication-title: PLoS One doi: 10.1371/journal.pone.0040865 – volume: 180 start-page: 28 issue: 1–2 year: 2015 ident: ppat.1012128.ref077 article-title: Immune response of porcine alveolar macrophages to a concurrent infection with porcine reproductive and respiratory syndrome virus and Haemophilus parasuis in vitro publication-title: Vet Microbiol doi: 10.1016/j.vetmic.2015.08.026 – volume: 86 start-page: 1316 issue: 3 year: 2012 ident: ppat.1012128.ref064 article-title: Inoculation of swine with foot-and-mouth disease SAP-mutant virus induces early protection against disease publication-title: J Virol doi: 10.1128/JVI.05941-11 – volume: 167 start-page: 1 issue: 1–2 year: 2015 ident: ppat.1012128.ref068 article-title: Innate and adaptive immunity against Porcine Reproductive and Respiratory Syndrome Virus publication-title: Vet Immunol Immunopathol doi: 10.1016/j.vetimm.2015.07.003 – volume: 25 start-page: 402 issue: 4 year: 2001 ident: ppat.1012128.ref079 article-title: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. publication-title: Methods doi: 10.1006/meth.2001.1262 – volume: 67 start-page: 47 issue: 1 year: 1999 ident: ppat.1012128.ref023 article-title: Differential production of proinflammatory cytokines in the pig lung during different respiratory virus infections: correlations with pathogenicity publication-title: Res Vet Sci doi: 10.1053/rvsc.1998.0277 – volume: 174 start-page: 4465 issue: 8 year: 2005 ident: ppat.1012128.ref005 article-title: Type I IFNs provide a third signal to CD8 T cells to stimulate clonal expansion and differentiation publication-title: J Immunol doi: 10.4049/jimmunol.174.8.4465 – volume: 90 start-page: e0057421 issue: 4 year: 2022 ident: ppat.1012128.ref080 article-title: Bacillus-Based Direct-Fed Microbial Reduces the Pathogenic Synergy of a Coinfection with Salmonella enterica Serovar Choleraesuis and Porcine Reproductive and Respiratory Syndrome Virus publication-title: Infect Immun doi: 10.1128/iai.00574-21 – volume: 202 start-page: 637 issue: 5 year: 2005 ident: ppat.1012128.ref008 article-title: Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection publication-title: J Exp Med doi: 10.1084/jem.20050821 – volume: 8 start-page: 13341 issue: 1 year: 2018 ident: ppat.1012128.ref039 article-title: Viral communities associated with porcine respiratory disease complex in intensive commercial farms in Sichuan province, China. publication-title: Sci Rep doi: 10.1038/s41598-018-31554-8 – volume: 82 start-page: 10964 issue: 22 year: 2008 ident: ppat.1012128.ref019 article-title: Early B-cell activation after West Nile virus infection requires alpha/beta interferon but not antigen receptor signaling publication-title: J Virol doi: 10.1128/JVI.01646-08 – volume: 37 start-page: e24881 issue: 7 year: 2023 ident: ppat.1012128.ref055 article-title: IL-6 at the center of cytokine storm: Circulating inflammation mediators as biomarkers in hospitalized COVID-19 patients. publication-title: J Clin Lab Anal. doi: 10.1002/jcla.24881 – volume: 176 start-page: 4682 issue: 8 year: 2006 ident: ppat.1012128.ref009 article-title: Direct stimulation of T cells by type I IFN enhances the CD8+ T cell response during cross-priming publication-title: J Immunol doi: 10.4049/jimmunol.176.8.4682 – volume: 39 start-page: 517 issue: 5 year: 2017 ident: ppat.1012128.ref041 article-title: Cytokine storm and sepsis disease pathogenesis publication-title: Semin Immunopathol doi: 10.1007/s00281-017-0639-8 – volume: 4 start-page: 424 issue: 4 year: 2012 ident: ppat.1012128.ref035 article-title: Interplay between interferon-mediated innate immunity and porcine reproductive and respiratory syndrome virus publication-title: Viruses doi: 10.3390/v4040424 – volume: 14 start-page: 1159590 year: 2023 ident: ppat.1012128.ref051 article-title: Streptococcus suis contributes to inguinal lymph node lesions in piglets after highly pathogenic porcine reproductive and respiratory syndrome virus infection. publication-title: Front Microbiol. doi: 10.3389/fmicb.2023.1159590 – volume: 92 issue: 2 year: 2018 ident: ppat.1012128.ref071 article-title: Genotype 2 Strains of Porcine Reproductive and Respiratory Syndrome Virus Dysregulate Alveolar Macrophage Cytokine Production via the Unfolded Protein Response publication-title: J Virol – volume: 37 start-page: 143 issue: 2 year: 2000 ident: ppat.1012128.ref038 article-title: Pathogenesis of porcine reproductive and respiratory syndrome virus-induced increase in susceptibility to Streptococcus suis infection publication-title: Vet Pathol doi: 10.1354/vp.37-2-143 – volume: 176 start-page: 4525 issue: 8 year: 2006 ident: ppat.1012128.ref004 article-title: CD8 T cells specific for lymphocytic choriomeningitis virus require type I IFN receptor for clonal expansion publication-title: J Immunol doi: 10.4049/jimmunol.176.8.4525 – volume: 581 start-page: 145 year: 2006 ident: ppat.1012128.ref075 article-title: The nuclear localization signal of the PRRS virus nucleocapsid protein viral replication in vitro and antibody response in vivo publication-title: Adv Exp Med Biol doi: 10.1007/978-0-387-33012-9_25 – volume: 11 start-page: e0156019 issue: 5 year: 2016 ident: ppat.1012128.ref043 article-title: Transcriptional Analysis of PRRSV-Infected Porcine Dendritic Cell Response to Streptococcus suis Infection Reveals Up-Regulation of Inflammatory-Related Genes Expression. publication-title: PLoS One doi: 10.1371/journal.pone.0156019 – volume: 4 start-page: 1009 issue: 10 year: 2003 ident: ppat.1012128.ref010 article-title: Cross-priming of CD8+ T cells stimulated by virus-induced type I interferon publication-title: Nat Immunol doi: 10.1038/ni978 – volume: 90 start-page: 498 issue: 5 year: 2012 ident: ppat.1012128.ref020 article-title: Role of type I interferons in the activation of autoreactive B cells publication-title: Immunol Cell Biol doi: 10.1038/icb.2012.10 – volume: 212 start-page: 1 year: 2016 ident: ppat.1012128.ref040 article-title: Porcine respiratory disease complex: Interaction of vaccination and porcine circovirus type 2, porcine reproductive and respiratory syndrome virus, and Mycoplasma hyopneumoniae. publication-title: Vet J. doi: 10.1016/j.tvjl.2015.10.030 – volume: 196 start-page: 60 year: 2015 ident: ppat.1012128.ref078 article-title: Transcription analysis on response of porcine alveolar macrophages to co-infection of the highly pathogenic porcine reproductive and respiratory syndrome virus and Mycoplasma hyopneumoniae publication-title: Virus Res doi: 10.1016/j.virusres.2014.11.006 – volume: 13 start-page: 3 issue: 1 year: 2016 ident: ppat.1012128.ref042 article-title: The cytokine storm of severe influenza and development of immunomodulatory therapy publication-title: Cell Mol Immunol doi: 10.1038/cmi.2015.74 – volume: 398 start-page: 87 issue: 1 year: 2010 ident: ppat.1012128.ref028 article-title: Identification of two auto-cleavage products of nonstructural protein 1 (nsp1) in porcine reproductive and respiratory syndrome virus infected cells: nsp1 function as interferon antagonist. publication-title: Virology doi: 10.1016/j.virol.2009.11.033 – volume: 84 start-page: 11045 issue: 21 year: 2010 ident: ppat.1012128.ref030 article-title: Porcine reproductive and respiratory syndrome virus inhibits type I interferon signaling by blocking STAT1/STAT2 nuclear translocation publication-title: J Virol doi: 10.1128/JVI.00655-10 – volume: 23 start-page: 532 issue: 4 year: 2022 ident: ppat.1012128.ref057 article-title: IL-1 and IL-1ra are key regulators of the inflammatory response to RNA vaccines publication-title: Nat Immunol doi: 10.1038/s41590-022-01160-y – volume: 16 start-page: 27 year: 1998 ident: ppat.1012128.ref056 article-title: Interleukin-1 receptor antagonist: role in biology publication-title: Annu Rev Immunol doi: 10.1146/annurev.immunol.16.1.27 – volume: 342 start-page: 47 issue: 1 year: 2005 ident: ppat.1012128.ref074 article-title: Porcine arterivirus activates the NF-kappaB pathway through IkappaB degradation publication-title: Virology doi: 10.1016/j.virol.2005.07.034 – volume: 32 start-page: 513 year: 2014 ident: ppat.1012128.ref001 article-title: Interferon-stimulated genes: a complex web of host defenses publication-title: Annu Rev Immunol doi: 10.1146/annurev-immunol-032713-120231 – volume: 23 start-page: 457 issue: 5 year: 2010 ident: ppat.1012128.ref059 article-title: Porcine reproductive and respiratory syndrome virus-induced immunosuppression exacerbates the inflammatory response to porcine respiratory coronavirus in pigs publication-title: Viral Immunol doi: 10.1089/vim.2010.0051 – volume: 407 start-page: 268 issue: 2 year: 2010 ident: ppat.1012128.ref031 article-title: Nonstructural protein 1α subunit-based inhibition of NF-κB activation and suppression of interferon-β production by porcine reproductive and respiratory syndrome virus publication-title: Virology doi: 10.1016/j.virol.2010.08.025 – volume: 178 start-page: 5839 issue: 9 year: 2007 ident: ppat.1012128.ref017 article-title: Vesicular stomatitis virus glycoprotein displaying retrovirus-like particles induce a type I IFN receptor-dependent switch to neutralizing IgG antibodies publication-title: J Immunol doi: 10.4049/jimmunol.178.9.5839 – volume: 17 start-page: 551 issue: 3 year: 2001 ident: ppat.1012128.ref048 article-title: Immunology of the porcine respiratory disease complex publication-title: Vet Clin North Am Food Anim Pract doi: 10.1016/S0749-0720(15)30006-2 – volume: 302 start-page: 9 issue: 1 year: 2002 ident: ppat.1012128.ref067 article-title: Passive transfer of virus-specific antibodies confers protection against reproductive failure induced by a virulent strain of porcine reproductive and respiratory syndrome virus and establishes sterilizing immunity publication-title: Virology doi: 10.1006/viro.2002.1612 – volume: 194 start-page: 100 year: 2014 ident: ppat.1012128.ref029 article-title: Modulation of innate immune signaling by nonstructural protein 1 (nsp1) in the family Arteriviridae. publication-title: Virus Res doi: 10.1016/j.virusres.2014.09.007 – volume: 66 start-page: 729 issue: 2 year: 2019 ident: ppat.1012128.ref060 article-title: Porcine reproductive and respiratory syndrome virus NADC30-like strain accelerates Streptococcus suis serotype 2 infection in vivo and in vitro publication-title: Transbound Emerg Dis doi: 10.1111/tbed.13072 – volume: 88 start-page: 14040 issue: 24 year: 2014 ident: ppat.1012128.ref014 article-title: Type I interferon signaling enhances CD8+ T cell effector function and differentiation during murine gammaherpesvirus 68 infection publication-title: J Virol doi: 10.1128/JVI.02360-14 – volume: 7 start-page: e1002407 issue: 12 year: 2011 ident: ppat.1012128.ref012 article-title: A temporal role of type I interferon signaling in CD8+ T cell maturation during acute West Nile virus infection publication-title: PLoS Pathog doi: 10.1371/journal.ppat.1002407 – volume: 204 start-page: 35 year: 2017 ident: ppat.1012128.ref044 article-title: Secondary Haemophilus parasuis infection enhances highly pathogenic porcine reproductive and respiratory syndrome virus (HP-PRRSV) infection-mediated inflammatory responses. publication-title: Vet Microbiol doi: 10.1016/j.vetmic.2017.03.035 – volume: 183 start-page: 1695 issue: 3 year: 2009 ident: ppat.1012128.ref013 article-title: Gene regulation and chromatin remodeling by IL-12 and type I IFN in programming for CD8 T cell effector function and memory publication-title: J Immunol doi: 10.4049/jimmunol.0900592 – volume: 111 start-page: E2172 issue: 21 year: 2014 ident: ppat.1012128.ref063 article-title: Transactivation of programmed ribosomal frameshifting by a viral protein publication-title: Proc Natl Acad Sci U S A – volume: 73 start-page: 270 issue: 1 year: 1999 ident: ppat.1012128.ref025 article-title: Porcine reproductive and respiratory syndrome virus comparison: divergent evolution on two continents publication-title: J Virol doi: 10.1128/JVI.73.1.270-280.1999 – volume: 14 start-page: 269 issue: 3 year: 2007 ident: ppat.1012128.ref066 article-title: Protection against porcine reproductive and respiratory syndrome virus (PRRSV) infection through passive transfer of PRRSV-neutralizing antibodies is dose dependent. publication-title: Clin Vaccine Immunol doi: 10.1128/CVI.00304-06 – volume: 22 start-page: 2552 issue: 11 year: 2003 ident: ppat.1012128.ref070 article-title: NF-kappaB and virus infection: who controls whom publication-title: Embo j doi: 10.1093/emboj/cdg267 – volume: 493 start-page: 52 year: 2016 ident: ppat.1012128.ref011 article-title: Type 1 interferon licenses naïve CD8 T cells to mediate anti-viral cytotoxicity publication-title: Virology doi: 10.1016/j.virol.2016.03.005 – volume: 61 start-page: 49 issue: 1 year: 1998 ident: ppat.1012128.ref021 article-title: Immune responses in pigs infected with porcine reproductive and respiratory syndrome virus (PRRSV). publication-title: Vet Immunol Immunopathol doi: 10.1016/S0165-2427(97)00134-7 – volume: 517 start-page: 177 year: 2018 ident: ppat.1012128.ref062 article-title: Type I interferon suppression-negative and host mRNA nuclear retention-negative mutation in nsp1β confers attenuation of porcine reproductive and respiratory syndrome virus in pigs publication-title: Virology doi: 10.1016/j.virol.2018.01.016 – volume: 135 start-page: 314 issue: 3–4 year: 2010 ident: ppat.1012128.ref072 article-title: Expression of inflammatory cytokines and Toll-like receptors in the brain and respiratory tract of pigs infected with porcine reproductive and respiratory syndrome virus publication-title: Vet Immunol Immunopathol doi: 10.1016/j.vetimm.2010.01.002 – volume: 177 start-page: 1746 issue: 3 year: 2006 ident: ppat.1012128.ref016 article-title: Innate inflammatory signals induced by various pathogens differentially dictate the IFN-I dependence of CD8 T cells for clonal expansion and memory formation publication-title: J Immunol doi: 10.4049/jimmunol.177.3.1746 – volume: 32 start-page: 648 issue: 6 year: 1995 ident: ppat.1012128.ref081 article-title: Comparison of the pathogenicity of two US porcine reproductive and respiratory syndrome virus isolates with that of the Lelystad virus publication-title: Vet Pathol doi: 10.1177/030098589503200606 – volume: 176 start-page: 2074 issue: 4 year: 2006 ident: ppat.1012128.ref003 article-title: Cutting edge: enhancement of antibody responses through direct stimulation of B and T cells by type I IFN publication-title: J Immunol doi: 10.4049/jimmunol.176.4.2074 – volume: 9 start-page: 83 year: 2012 ident: ppat.1012128.ref036 article-title: Porcine reproductive and respiratory syndrome virus nonstructural protein 2 contributes to NF-κB activation. publication-title: Virol J. doi: 10.1186/1743-422X-9-83 – volume: 88 start-page: 10934 issue: 18 year: 2014 ident: ppat.1012128.ref034 article-title: Porcine reproductive and respiratory syndrome virus nonstructural protein 4 antagonizes beta interferon expression by targeting the NF-κB essential modulator publication-title: J Virol doi: 10.1128/JVI.01396-14 – volume: 402 start-page: 315 issue: 2 year: 2010 ident: ppat.1012128.ref047 article-title: Modulation of type I interferon induction by porcine reproductive and respiratory syndrome virus and degradation of CREB-binding protein by non-structural protein 1 in MARC-145 and HeLa cells publication-title: Virology doi: 10.1016/j.virol.2010.03.039 – volume: 6 start-page: 24401 year: 2016 ident: ppat.1012128.ref045 article-title: Matrine displayed antiviral activity in porcine alveolar macrophages co-infected by porcine reproductive and respiratory syndrome virus and porcine circovirus type 2. publication-title: Sci Rep.PubMed Central PMCID – volume: 90 start-page: 2713 issue: Pt 11 year: 2009 ident: ppat.1012128.ref058 article-title: Porcine reproductive and respiratory syndrome virus modifies innate immunity and alters disease outcome in pigs subsequently infected with porcine respiratory coronavirus: implications for respiratory viral co-infections publication-title: J Gen Virol doi: 10.1099/vir.0.014001-0 – volume: 93 issue: 14 year: 2019 ident: ppat.1012128.ref032 article-title: Porcine Reproductive and Respiratory Syndrome Virus Nonstructural Protein 1 Beta Interacts with Nucleoporin 62 To Promote Viral Replication and Immune Evasion publication-title: J Virol – volume: 19 start-page: 331 issue: 2 year: 2013 ident: ppat.1012128.ref050 article-title: Streptococcus suis and porcine reproductive and respiratory syndrome, Vietnam publication-title: Emerg Infect Dis doi: 10.3201/eid1902.120470 – volume: 346 start-page: 238 issue: 1 year: 2006 ident: ppat.1012128.ref052 article-title: Mutations within the nuclear localization signal of the porcine reproductive and respiratory syndrome virus nucleocapsid protein attenuate virus replication publication-title: Virology doi: 10.1016/j.virol.2005.11.005 – start-page: 231 year: 2002 ident: ppat.1012128.ref049 article-title: Porcine Respiratory Disease Complex. publication-title: Polymicrobial Diseases – volume: 48 start-page: 586 issue: 4 year: 2011 ident: ppat.1012128.ref053 article-title: Porcine reproductive and respiratory syndrome virus (PRRSV) infection activates chemokine RANTES in MARC-145 cells. publication-title: Mol Immunol doi: 10.1016/j.molimm.2010.10.022 – volume: 135 start-page: 107 issue: 1 year: 2008 ident: ppat.1012128.ref076 article-title: Functional mapping of the porcine reproductive and respiratory syndrome virus capsid protein nuclear localization signal and its pathogenic association publication-title: Virus Res doi: 10.1016/j.virusres.2008.02.012 – volume: 185 start-page: 1419 issue: 3 year: 2010 ident: ppat.1012128.ref006 article-title: IFN-alpha beta and self-MHC divert CD8 T cells into a distinct differentiation pathway characterized by rapid acquisition of effector functions publication-title: J Immunol doi: 10.4049/jimmunol.1001140 – volume: 145 start-page: 2297 issue: 11 year: 2000 ident: ppat.1012128.ref026 article-title: Full-length sequence of a Canadian porcine reproductive and respiratory syndrome virus (PRRSV) isolate. publication-title: Arch Virol doi: 10.1007/s007050070022 – volume: 27 start-page: 493 issue: 3 year: 1938 ident: ppat.1012128.ref083 article-title: A SIMPLE METHOD OF ESTIMATING FIFTY PER CENT ENDPOINTS. publication-title: American Journal of Epidemiology doi: 10.1093/oxfordjournals.aje.a118408 – volume: 64 start-page: 33 issue: 1 year: 2023 ident: ppat.1012128.ref054 article-title: Identification of Parameters Representative of Immune Dysfunction in Patients with Severe and Fatal COVID-19 Infection: a Systematic Review and Meta-analysis publication-title: Clin Rev Allergy Immunol doi: 10.1007/s12016-021-08908-8 – volume: 25 start-page: 50 issue: 2 year: 2000 ident: ppat.1012128.ref046 article-title: A novel superfamily of predicted cysteine proteases from eukaryotes, viruses and Chlamydia pneumoniae publication-title: Trends Biochem Sci doi: 10.1016/S0968-0004(99)01530-3 |
SSID | ssj0041316 |
Score | 2.469895 |
Snippet | Porcine reproductive and respiratory syndrome virus (PRRSV) is known to suppress the type I interferon (IFNs-α/β) response during infection. PRRSV also... Porcine reproductive and respiratory syndrome virus (PRRSV) is known to suppress the type I interferon (IFNs-[alpha]/[beta]) response during infection. PRRSV... |
SourceID | plos doaj pubmedcentral proquest gale pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | e1012128 |
SubjectTerms | Adaptive immunity Alveoli Amino acids Analysis Animal diseases Animals antagonists Antibodies B cells Bacteria Bacterial infections Betaarterivirus suid 2 Biological response modifiers Biology and Life Sciences Care and treatment Chemokines Coronaviruses Cytokines Diagnosis disease severity domain Gene expression Gene mutations genes Genetic aspects genetic engineering Genetic modification Genetically modified organisms Genetics Genomes Health aspects Immunology Infection Infections Inflammation Interferon interferons Leucine Livestock farms Localization Lymphocytes Macrophages Medical research Medicine and Health Sciences Medicine, Experimental mixed infection Mutants Mutation N gene NF-κB protein nuclear localization signals nucleocapsid Nucleocapsids Pathogens phenotype Phenotypes Porcine reproductive and respiratory syndrome Pork industry Proteins Respiratory diseases Respiratory tract diseases reverse genetics Signal transduction Swine vaccines Viral diseases Viral infections viral nonstructural proteins Viremia Virus diseases Viruses β-Interferon |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9RADB6hSkhcEO8uFDQgJE6h2cz7uCCqgkQPQKXeonmFVt1NVpsEsT-S_4Sdx6pBhV64ZjyWZuyxPRn7MyGvtbdCOq6TAN4hQYypxAhXJNpZplXBZNHhzH4-kcen_NOZOLvS6gtzwnp44H7jDjl4QK64CVmqeWFS47m0aRTWMy9iVzydgc8bL1O9DQbL3DU9xaY4iWJSDkVzTM0PBxm9Xa9tBx8NtltPnFKH3b-z0HvrZVVfF37-mUV5xS0d3SN3h3iSLvp13Ce3YvmA3O47TG4fkl8LOtY-LrcUsTTLFqLLQEPVumVMVi12EaZVQSEOxzd2iiiXHQgsmEFqywAfdo_xdMQ3oD8uNm2dZLQ5tw3wijUtq4bCzNUauMHxiD-HDNuyY76pQJNB-VY9H79tqktMuKd9mST1VTKmhZUU_w1TS2u8qwcL5Ng2uQJNf0ROjz58e3-cDB0cEi-NaMDGOxULHZ1KTcEthhPCpSEGw5xkPvVMSG7mLNjCARmz2ILU62iyALoSA3tM9sqqjPuESgjt5oW3Oi0Edz41oABwF5JOm8hdyGaEjSLM_QBvjl02lnn3ZqfgmtNLJEfB54PgZyTZzVr38B430L9D7djRIjh39wFUNh9UNr9JZWfkFepWjvAbJeb3fLdtXecfv57kC6U1k4ip_1eiLxOiNwNRUcFivR1qKmDLENZrQnkwoQQj4ifD-6jn45rrHG6SZo4FeQpmjrp__fDL3TAyxZy9MlYt0oCvUBmT6T9owOFKY4TiM_KkP067vWVacJUJGNGTgzbZ_OlIeXHeIaQjDiLw5U__h7iekTsZUGDiYaYPyF6zaeNziEQb96IzOr8BbT2K_A priority: 102 providerName: Directory of Open Access Journals – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1Lb9QwELagCIkL4t2FggxC4hTIxo4fJ1QQVUGiB6BSb5HtOG3FNl42CaI_kv_ETOIEgkq5xp9HiWc8ntjjbwh5rpzJheUqKWF1SJBjKtG5rRJlDVOyYqLqeWY_Hoj9Q_7hKD-KG25NTKscfWLvqMvgcI_8FYS2eok3hOTr9bcEq0bh6WosoXGVXEPqMkzpkkfTDxf45770KZbGSSQTIl6dY3L5Kmrq5XptehJp8OBqtjT1DP6Tn95ar0JzURD6dy7lH4vT3i1yM0aVdHcwg9vkiq_vkOtDncnzu-TnLh1vQK7OKTJq1h3EmCUtQ2dXPjnrsJYwDRWFaBxP2ilyXfZUsOAMqalLeDAdydOR5YB-P910TZLR9sS0IMs3tA4thZ5na5AGk8T_iHm2dS98E8CewQTPBjnuvA1fMe2eDpclqQvJmBxWU9whpoY2-MdeGoBj8eQA9n6PHO69-_J2P4l1HBIndN6Cp7fSV8pbmeqKGwwqcpuWvtTMCuZSx3LB9ZKVprIAYwYLkTrldVaCxfiS3Sdbdaj9NqECArxl5YxKq5xbl2rjIKDiwirtuS2zBWGjCgsXSc6x1saq6E_uJPzsDBopUPFFVPyCJFOv9UDy8R_8G7SOCYsU3f2DsDku4owvOIRuXHJdZqnilU6148KkPoc3drnPlwvyDG2rQBKOGrN8jk3XNMX7zwfFrlSKCWTW_yfo0wz0IoKqAB_rTLxZAUOG5F4z5M4MCa7EzZq30c7Hb26K35MOeo62f3Hz06kZhWLmXu1DhxhYMWTGRHoJBpZdoXUu-YI8GKbTNLZM5VxmObSo2USbDf68pT496XnSkQ0R5PKHl7_7I3IjA1VhYmGmdshWu-n8Y4g0W_ukdye_AEcJg5s priority: 102 providerName: ProQuest |
Title | A clinically attenuated double-mutant of porcine reproductive and respiratory syndrome virus-2 that does not prompt overexpression of proinflammatory cytokines during co-infection with a secondary pathogen |
URI | https://www.ncbi.nlm.nih.gov/pubmed/38547254 https://www.proquest.com/docview/3069183357 https://www.proquest.com/docview/3022572360 https://www.proquest.com/docview/3153699574 https://pubmed.ncbi.nlm.nih.gov/PMC11003694 https://doaj.org/article/41024749d2084f909c46a0e5ac3c5e51 http://dx.doi.org/10.1371/journal.ppat.1012128 |
Volume | 20 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELb6EBIXxLsLZWUQEqdU2diO7QNCLWpVkFqhQqXeIttx2qrbZNkkqPsj-U_M5CWCWhDXeDxKxvNyPP6GkLfKGRFbroIUokOAGFOBFjYLlDVMyYzFWYMze3QcH57yz2fibI30PVs7AZa3bu2wn9Tpcr5z8331AQz-fdO1Qc76STuLhWkAocEbq3WyCbFJoqke8eFcATx20wwVm-UEkkneXaa7i8soWDWY_oPn3ljMi_K2tPTP6srfwtXBQ_KgyzPpbqsYj8iazx-Te23nydUT8nOX9nci5yuKGJt5DVlnStOitnMfXNfYXZgWGQXR4Nk7RfTLBhwW3CM1eQoPhkN62uMe0B-Xy7oMIlpdmAp4-ZLmRUVh5vUCuIHZ-Juu8jZvmC8LkDko5XXLx62q4goL8Wl7fZK6IujLxXKK_4ypoSXu4VMD5NhOuQALeEpOD_a_fTwMus4OgYu1qMD3W-kz5a0MdcYNphnChqlPNbMxc6FjIuZ6xlKTWSBjBluTOuV1lIIO-ZQ9Ixt5kfstQmNI-WaZMyrMBLcu1MZBisVjq7TnNo0mhPVLmLgO9hy7b8yT5ixPwvanXZEEFz7pFn5CgmHWooX9-Af9HmrHQIug3c2DYnmedD4g4ZDMccl1GoWKZzrUjscm9ALe2AkvZhPyBnUrQViOHOt-zk1dlsmnr8fJrlSKxYi1fyfRyYjoXUeUFfCxznR3LUBkCPc1otweUYJzcaPhLdTz_pvLBHaYeoYX9STM7HX_9uHXwzAyxVq-3Bc10kAMkRGLw7_QQCCOtRaST8jz1pwG2TIluIwEjKiRoY2EPx7JLy8a5HTERwS-_MV_Lu9Lcj-CtcPaw0htk41qWftXkIxWdkrW5Zmcks29_eMvJ9Pml8608Tm_AK8Wkww |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELbKVgguiHcXChgE4hSajZ3EPiC0hVZb2q5QaaXegu04bcVusmwSYP8U_4T_xEweC0GlnHqNJ6Mk84w98w0hz4VRfqC5cGKIDg5iTDnS14kjtGIiTFiQVDiz--NgdMTfH_vHK-RH2wuDZZWtT6wcdZwZ3CPfgNRWDrBDKHwz--Lg1Cg8XW1HaNRqsWsX3-CXLX-98w7k-8LztrcO346cZqqAYwLpF-B3dGgTYXXoyoQrDHG-dmMbS6YDZlzD_IDLAYtVooGMKRyLaYSVXgzPb2MGfK-QVc7gV6ZHVje3xh8OWt8PEaEatorDeJyQBUHTrMfCwUajG69mM1XBVkPMEJ1gWM0MWEaG3myS5eelvX9Xb_4RDrdvkhtNHkuHteLdIis2vU2u1pMtF3fIzyFtey4nC4oYnmkJWW1M46zUE-tMS5xeTLOEQv6PZ_sU0TUr8Flwv1SlMVxYFgHQFleBfj2bl7nj0eJUFcDL5jTNCgp3TmfADczSfm8qe9OK-TwDCwKln9Z8zKLIPmOhP63bM6nJnLYcLaW4J00VzXGPIFZAjuOaM7Cwu-ToUmR8j_TSLLVrhAaQUg4So4Sb-FwbVyoDKRwPtJCW69jrE9aKMDINrDpO95hE1VlhCL9XtUQiFHzUCL5PnOVdsxpW5D_0m6gdS1oEBa8uZPOTqPExEYdkkYdcxp4reCJdaXigXOvDExvf-oM-eYa6FSHsR4p1RSeqzPNo5-M4GoZCsACx_P9JdNAhetkQJRm8rFFNLwd8MoQT61CudyjBeZnO8hrqefvOefTbzOHOVvfPX366XEamWCuY2qxEGohRoQf2eQENBPpASj_kfXK_Nqflt2XC56Hnw4roGFrn43dX0rPTCpkd8ReBL39w8bM_IddGh_t70d7OePchue6B2LCs0RPrpFfMS_sI8txCP26cCyWfLtuf_QKxHcMw |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELZKEYgL4t2FAgaBOIVm4_cBoUKpWgoVAir1FhzHaSu2ybJJgP1r_Af-EzN5LASVcuo1Ho_izNPO-BtCHmlnhUy4DlKIDgFiTAVGJFmgE8u0ypjMGpzZt7tya4-_3hf7S-RHfxcGyyp7n9g46rRweEa-BqmtGeMNIbWWdWUR7zY2n0-_BNhBCv-09u00WhXZ8fNvsH0rn21vgKwfR9Hmq48vt4Kuw0DgpBEV-KBE-Uz7RIUm4xbDnUjC1KeGJZK50DEhuRmz1GYJkDGLLTKd9iZKYS0-ZcD3HDmvmBijjan9xWYPYkPTdhXb8gSKSdld22NqvNZpydPp1DYA1hA99CAsNt0DFjFieTopypMS4L_rOP8IjJtXyOUuo6XrrQpeJUs-v0YutD0u59fJz3Xa376czCmieeY15LcpTYs6mfjguMY-xrTIKOwE8C8_RZzNBoYWHDG1eQoPFuUAtEdYoF-PZnUZRLQ6tBXw8iXNi4rCzOMpcAMD9d-7Gt-8YT4rwJZA_Y9bPm5eFZ-x5J-2FzWpK4K-MC2neDpNLS3xtCC1QI6NmwuwtRtk70wkfJMs50XuVwiVkFyOM2d1mAmeuNBYB8kcl4k2nidpNCKsF2HsOoB17PMxiZu_hgo2Wq1EYhR83Al-RILFrGkLMPIf-heoHQtahAdvHhSzg7jzNjGHtJErbtIo1DwzoXFc2tALeGMnvBiPyEPUrRgBQHI0pQNbl2W8_WE3XldaM4mo_v8kej8getIRZQUs1tnuVgd8MgQWG1CuDijBjbnB8Arqeb_mMv5t8DCz1_2Thx8shpEpVg3mvqiRBqKVipgMT6GBkC-NEYqPyK3WnBbflmnBVSRgRA8MbfDxhyP50WGD0Y5IjMCX3z793e-Ti-DF4jfbuzt3yKUIpIb1jZFeJcvVrPZ3IeGtknuNZ6Hk01m7sl8VvsYA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+clinically+attenuated+double-mutant+of+porcine+reproductive+and+respiratory+syndrome+virus-2+that+does+not+prompt+overexpression+of+proinflammatory+cytokines+during+co-infection+with+a+secondary+pathogen&rft.jtitle=PLoS+pathogens&rft.au=Su%2C+Chia-Ming&rft.au=Kim%2C+Jineui&rft.au=Tang%2C+Junyu&rft.au=Hung%2C+Yu+Fan&rft.date=2024-03-28&rft.issn=1553-7374&rft.eissn=1553-7374&rft.volume=20&rft.issue=3&rft.spage=e1012128&rft_id=info:doi/10.1371%2Fjournal.ppat.1012128&rft.externalDBID=n%2Fa&rft.externalDocID=10_1371_journal_ppat_1012128 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1553-7374&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1553-7374&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1553-7374&client=summon |